Denali Therapeutics Inc (NAS:DNLI)
$ 25.69 +1.37 (+5.63%) Market Cap: 4.11 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 4.91 GF Score: 33/100

Denali Therapeutics Inc (DNLI) Transcripts

  • 1